Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Hebbar

Showing results (21-30 of 75) with videos related to

Pageof 8
Sort By:
La Revue De Medecine Interne|January 1, 1993
[Dermatopolymyositis and chronic lymphoid leukemia. Apropos of 2 cases]M Hebbar, D Gosset, B Dupriez, et al.
Arthritis and Rheumatism|April 15, 2000
Increased concentrations of the circulating angiogenesis inhibitor endostatin in patients with systemic sclerosisM Hebbar, J P Peyrat, L Hornez, et al.
Annales De Medecine Interne|January 1, 1995
Participation of cryoglobulinaemia in the severe peripheral neuropathies of primary Sjögren's syndromeM Hebbar, K Hebbar-Savean, E Hachulla, et al.
Journal of Chemotherapy (Florence, Italy)|August 5, 2008
Docetaxel therapy for advanced hepatocellular carcinoma developed in healthy liver: report of three casesO Romano, S Truant, G Sergent-Baudson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 2, 1999
Prognostic value of circulating soluble E-selectin concentrations in node-negative breast cancer patientsM Hebbar, F Révillion, M M Louchez, et al.
Leukemia|April 1, 1995
Association of myelodysplastic syndrome and relapsing polychondritis: further evidenceM Hebbar, M Brouillard, E Wattel, et al.
Anticancer Research|March 28, 2001
Distribution and prognostic value of the fibroblast growth factor-2 low-affinity binding sites in human breast cancerV D Blanckaert, L Hornez, M Hebbar, et al.
La Revue De Medecine Interne|July 1, 1997
[Gallium scintigraphy disclosing tumor of the small intestine!]M Lambert, M Hebbar, E Hachulla, et al.
Bulletin Du Cancer|January 1, 1995
[Insufficient efficacy of the use of a single 8 mg tablet of ondansetron in the prevention of nausea and vomiting induced by FEC chemotherapy]M Hebbar, B Hecquet, L Vanlemmens, et al.
Cancer Research|September 29, 1998
Multiplex reverse transcription polymerase chain reaction assessment of sialyltransferase expression in human breast cancerM A Recchi, M Hebbar, L Hornez, et al.
Pageof 8

Showing results (21-30 of 75) with videos related to

Sort By:
Pageof 8
La Revue De Medecine Interne|January 1, 1993
[Dermatopolymyositis and chronic lymphoid leukemia. Apropos of 2 cases]M Hebbar, D Gosset, B Dupriez, et al.
Arthritis and Rheumatism|April 15, 2000
Increased concentrations of the circulating angiogenesis inhibitor endostatin in patients with systemic sclerosisM Hebbar, J P Peyrat, L Hornez, et al.
Annales De Medecine Interne|January 1, 1995
Participation of cryoglobulinaemia in the severe peripheral neuropathies of primary Sjögren's syndromeM Hebbar, K Hebbar-Savean, E Hachulla, et al.
Journal of Chemotherapy (Florence, Italy)|August 5, 2008
Docetaxel therapy for advanced hepatocellular carcinoma developed in healthy liver: report of three casesO Romano, S Truant, G Sergent-Baudson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 2, 1999
Prognostic value of circulating soluble E-selectin concentrations in node-negative breast cancer patientsM Hebbar, F Révillion, M M Louchez, et al.
Leukemia|April 1, 1995
Association of myelodysplastic syndrome and relapsing polychondritis: further evidenceM Hebbar, M Brouillard, E Wattel, et al.
Anticancer Research|March 28, 2001
Distribution and prognostic value of the fibroblast growth factor-2 low-affinity binding sites in human breast cancerV D Blanckaert, L Hornez, M Hebbar, et al.
La Revue De Medecine Interne|July 1, 1997
[Gallium scintigraphy disclosing tumor of the small intestine!]M Lambert, M Hebbar, E Hachulla, et al.
Bulletin Du Cancer|January 1, 1995
[Insufficient efficacy of the use of a single 8 mg tablet of ondansetron in the prevention of nausea and vomiting induced by FEC chemotherapy]M Hebbar, B Hecquet, L Vanlemmens, et al.
Cancer Research|September 29, 1998
Multiplex reverse transcription polymerase chain reaction assessment of sialyltransferase expression in human breast cancerM A Recchi, M Hebbar, L Hornez, et al.
Pageof 8